| T cell receptor gene therapy for cancer TM Schmitt, GB Ragnarsson, PD Greenberg Human gene therapy 20 (11), 1240-1248, 2009 | 618 | 2009 |
| Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients AG Chapuis, GB Ragnarsson, HN Nguyen, CN Chaney, JS Pufnock, ... Science translational medicine 5 (174), 174ra27-174ra27, 2013 | 362 | 2013 |
| T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant AG Chapuis, DN Egan, M Bar, TM Schmitt, MS McAfee, KG Paulson, ... Nature medicine 25 (7), 1064-1072, 2019 | 292 | 2019 |
| Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin T Rafnar, GR Sigurjonsdottir, SN Stacey, G Halldorsson, P Sulem, ... JNCI: Journal of the National Cancer Institute 110 (9), 967-974, 2018 | 43 | 2018 |
| Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells GB Ragnarsson, EK Mikaelsdóttir, H Vidarsson, JG Jonasson, ... British journal of cancer 83 (12), 1715-1721, 2000 | 23 | 2000 |
| HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958–1960 and 1995–1996☆ EK Mikaelsdottir, KR Benediktsdottir, K Olafsdottir, T Arnadottir, ... Gynecologic oncology 89 (1), 22-30, 2003 | 17 | 2003 |
| Genetic variants associated with platelet count are predictive of human disease and physiological markers E Mikaelsdottir, G Thorleifsson, L Stefansdottir, G Halldorsson, ... Communications Biology 4 (1), 1132, 2021 | 14 | 2021 |
| EBV-specific donor cells transduced to express a high-affinity WT1 TCR can prevent recurrence in post-HCT patients with high-risk AML A Chapuis, DN Egan, M Bar, TM Schmitt, M McAfee, M Perdicchio, ... Blood 128 (22), 1001, 2016 | 7 | 2016 |
| Adoptive T Cell Therapy Targeting WT1 in Leukemia and MDS patients (41.34) G Ragnarsson, H Nguyen, C Chaney, B Ho, P Greenberg The Journal of Immunology 182 (1_Supplement), 41.34-41.34, 2009 | 2 | 2009 |
| Verða ný lyf í boði fyrir sjúklinga árið 2016? G Gröndal, GB Ragnarsson Læknablaðið, 2015 | 1 | 2015 |
| Ópíóíðaeitrun í kjölfar vórikónazólmeðferðar-sjúkratilfelli AB Ingason, MK Magnússon, GB Ragnarsson | | 2019 |
| Will new drugs become available to patients in the year 2016? G Grondal, GB Ragnarsson LAEKNABLADID 101 (10), 447-447, 2015 | | 2015 |
| Will there be new drugs for patients in Iceland 2016? G Gröndal, GB Ragnarsson Laeknabladid 101 (10), 447, 2015 | | 2015 |
| Transferred Donor-Derived WT1-Specific CD8+ T-Cell Clones After Hematopoietic Cell Transplantation Mediate Antileukemic Activity and Can Establish Persistent Responses without … AG Chapuis, GB Ragnarsson, H Nguyen, CN Chaney, J Pufnock, ... Blood 120 (21), 350, 2012 | | 2012 |
| Myeloablative Transplant (HCT) GB Ragnarsson, PJ Martin Leukemia and Related Disorders: Integrated Treatment Approaches, 169-186, 2012 | | 2012 |
| Generating therapeutic/protective T-cell responses to tumors and HIV:" More is better, but will it be enough?" PD Greenberg, R Teague, M Wolfl, W Ho, G Ragnarsson, J Kuball, ... Cancer Immunity 8 (Suppl_1), 7, 2008 | | 2008 |
| Analysis of apoptosis in breast tumors and infiltrating lymphocytes. T Rafnar, HM Ogmundsdottir, H Vidarsson, EK Mikaelsdottir, K Olafsdottir, ... FASEB JOURNAL 13 (4), A302-A302, 1999 | | 1999 |
